Pure Global

"Horiba" erythrolytic agent (unsterilized) - Taiwan Registration 91f474773973f4b20a0700cc85458ff6

Access comprehensive regulatory information for "Horiba" erythrolytic agent (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 91f474773973f4b20a0700cc85458ff6 and manufactured by HORIBA ABX SAS. The authorized representative in Taiwan is HORIBA TAIWAN, INC..

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including HORIBA ABX SAS, and 3 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
1 Competitors
3 Recent Registrations
91f474773973f4b20a0700cc85458ff6
Registration Details
Taiwan FDA Registration: 91f474773973f4b20a0700cc85458ff6
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Horiba" erythrolytic agent (unsterilized)
TW: "ๅ €ๅ ด" ็ด…่ก€็ƒๆบถ่งฃๅŠ‘ (ๆœชๆป…่Œ)
Risk Class 1

Registration Details

91f474773973f4b20a0700cc85458ff6

DHA09402291505

Company Information

France

Product Details

Limited to the classification and grading management measures for medical devices, the first level identification range of "red blood cell lytic agent (B.8540)".

B Hematology, pathology, and genetics

B.8540 ็ด…่ก€็ƒๆบถ่งฃๅŠ‘

Input;; QMS/QSD

Dates and Status

Sep 30, 2022

Sep 30, 2027

Companies Making Similar Products
Top companies providing products similar to ""Horiba" erythrolytic agent (unsterilized)"